| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02e53ab9f0535f243044954418c464d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f0f13c8bc40273eec5b42c6f633731c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 |
| filingDate |
2008-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b46446ad0cf56afa255db6d171fe921
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccc8e8a94299353f7b14a77f07f9d3c9 |
| publicationDate |
2008-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008151412-A1 |
| titleOfInvention |
Synergistic inhibition of h1n1 and h3n2 influenza viruses by aurintricarboxylic acid with amantadine |
| abstract |
Treatment of influenza virus infections by administering to an individual, for example, an effective amount of aurintricarboxylic acid (ATA) is herein described. In some embodiments, ATA is co-administered with amantadine, the combination having synergistic effects. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013053881-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2581080-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2527688-C2 |
| priorityDate |
2007-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |